Post-marketing Clinical Monitoring of Safety and Performance of Breast Tissue Expander for Breast Reconstruction

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorSilimed Industria de Implantes Ltda

About this trial

The study investigates the safety and performance of Silimed® brand breast tissue expander in women born with indication for breast reconstruction. The safety of the breast tissue expander will be evaluated by estimating known and unexpected adverse event rates through patient reports of adverse events after implantation. The performance of using Silimed® brand breast tissue expander will be evaluated by evaluating the assessment of tissue quality and satisfaction by the evaluating physician after implantation.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

provide written informed consent

female sex at birth;

be 18 years of age or older;

have an indication for reconstruction with breast expander + breast implant(s);

Disqualifiers

breast augmentation without reconstruction in at least one breast;

neoplasia of any type (except breast neoplasia), not yet treated or under treatment, or requiring surgical removal at the time of implantation;

pregnancy or breastfeeding at the time of implantation;

smoking, uncontrolled diabetes, obesity (from grade 2) and ASA III/IV;

Trial population

Born females with indication of breast reconstruction using Silimed brand breast tissue expander.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Breast tissue expander

    Device

    Silimed brand breast tissue expander

Treatment groups

152 Participants
are divided into 1 treatment group
Group A: Women undergoing breast reconstruction with Silimed® breast tissue expander.1 intervention

Trial outcomes

Primary outcomes

1

Adverse events

Estimate adverse events rate for breast tissue expander

Time frame
Through study completion, an average of 1 year
2

Evaluator's Satisfaction in Relation to expansion

Estimate the performance of Silimed® brand breast tissue expander with through the satisfaction of the evaluator (investigator) regarding the result of the expansion so far. The assessment will be done by means of a likert scale, where the following satisfaction options can be selected: 1 = definitely unsatisfied, 2 = unsatisfied, 3 = slightly satisfied, 4 = satisfied and 5 = definitely satisfied.

Time frame
Through study completion, an average of 1 year
3

Evaluator's Assessment of tissue quality

The assessment of tissue quality is clinical and will occur at every visit, including the final assessment. Estimate the performance of Silimed® brand breast tissue expander with textured surface throught the satisfaction of the evaluator regarding the vascularization, innervation, color and texture of and quality of the expanded tissue. To measure satisfaction, a Likert scale where the following satisfaction options can be marked: 1 = definitely dissatisfied, 2 = dissatisfied, 3 = somewhat satisfied, 4 = satisfied and 5 = definitely satisfied. Satisfaction will be measured in percentages of each category of the Likert scale in each follow-up time. Values from 0 to 20 will be considered poor results, bad results from 21 to 40, intermediate results from 41 to 60, good results from 61 to 80, and excellent results from 81 to 100.

Time frame
Through study completion, an average of 1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.